Possibia

4828265

Last Update Posted: 2022-01-31

Recruiting has ended

Males

accepted

18 Years-65 Years

36 Estimated Participants

No Expanded Access

Interventional Study

Accepts healthy volunteers

Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects

This is an open-label study to assess safety, tolerability, and pharmacokinetics of Aldafermin (NGM282) in healthy adult male Japanese and non-Japanese subjects

Eligibility

Relevant conditions:

Healthy Male

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov